These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Improved event-related potential signs of selective attention after the administration of the cholecystokinin analog ceruletide in healthy persons. Schreiber H; Stolz-Born G; Pietrowsky R; Kornhuber HH; Fehm HL; Born J Biol Psychiatry; 1995 May; 37(10):702-12. PubMed ID: 7640325 [TBL] [Abstract][Full Text] [Related]
4. The effects of low dose ketamine on sensory gating, neuroendocrine secretion and behavior in healthy human subjects. van Berckel BN; Oranje B; van Ree JM; Verbaten MN; Kahn RS Psychopharmacology (Berl); 1998 Jun; 137(3):271-81. PubMed ID: 9683005 [TBL] [Abstract][Full Text] [Related]
5. Influences of cortisol on auditory evoked potentials (AEPs) and mood in humans. Born J; Hitzler V; Pietrowsky R; Pauschinger P; Fehm HL Neuropsychobiology; 1989; 20(3):145-51. PubMed ID: 2761685 [TBL] [Abstract][Full Text] [Related]
6. Effects of cocaine on P3B in cocaine abusers. Herning RI; Glover BJ; Guo X Neuropsychobiology; 1994; 30(2-3):132-42. PubMed ID: 7800160 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of cognitive skills in ethanol- and cocaine- dependent patients during detoxification using P300 evoked response potentials (ERPs). Amass L; Lukas SE; Weiss RD; Mendelson J NIDA Res Monogr; 1989; 95():353-4. PubMed ID: 2640992 [No Abstract] [Full Text] [Related]
8. Late auditory evoked potentials: a method for monitoring drug effects on the central nervous system. Noldy NE; Neiman J; el-Nesr B; Carlen PL Neuropsychobiology; 1990; 23(1):48-52. PubMed ID: 2280830 [TBL] [Abstract][Full Text] [Related]
9. Effects of corticotropin releasing hormone on human brain function: an analysis based on auditory evoked potentials. Fehm HL; Born J Horm Metab Res Suppl; 1987; 16():75-9. PubMed ID: 2832298 [TBL] [Abstract][Full Text] [Related]
10. ACTH and attention in humans: a review. Born J; Fehm HL; Voigt KH Neuropsychobiology; 1986; 15(3-4):165-86. PubMed ID: 3024062 [TBL] [Abstract][Full Text] [Related]
11. P300, clinical symptoms, and neuropsychological parameters in acute and remitted schizophrenia: a preliminary report. Eikmeier G; Lodemann E; Zerbin D; Gastpar M Biol Psychiatry; 1992 May; 31(10):1065-9. PubMed ID: 1511077 [No Abstract] [Full Text] [Related]
12. Auditory event-related potentials, auditory digit span, and clinical symptoms in chronic schizophrenic men on neuroleptic medication. Stefánsson SB; Jónsdóttir TJ Biol Psychiatry; 1996 Jul; 40(1):19-27. PubMed ID: 8780851 [TBL] [Abstract][Full Text] [Related]
13. The effects of some antidepressant drugs on prepulse inhibition of the acoustic startle (eyeblink) response and the N1/P2 auditory evoked response in man. Phillips MA; Langley RW; Bradshaw CM; Szabadi E J Psychopharmacol; 2000 Mar; 14(1):40-5. PubMed ID: 10757252 [TBL] [Abstract][Full Text] [Related]
14. Auditory event-related potentials and electrodermal activity in medicated and unmedicated schizophrenics. Roth WT; Goodale J; Pfefferbaum A Biol Psychiatry; 1991 Mar; 29(6):585-99. PubMed ID: 1675890 [TBL] [Abstract][Full Text] [Related]
15. Vasopressin and electrophysiological signs of attention in man. Born J; Fehm-Wolfsdorf G; Lutzenberger W; Voigt KH; Fehm HL Peptides; 1986; 7(2):189-93. PubMed ID: 3737444 [TBL] [Abstract][Full Text] [Related]
16. Dose-dependent influences on electrophysiological signs of attention in humans after neuropeptide ACTH 4-10. Born J; Bräuninger W; Fehm-Wolfsdorf G; Voigt KH; Pauschinger P; Fehm HL Exp Brain Res; 1987; 67(1):85-92. PubMed ID: 3040455 [TBL] [Abstract][Full Text] [Related]
17. Altered P300 topography due to functional and structural disturbances in the limbic system in dementia and psychoses and to pharmacological conditions. Maurer K; Riederer P; Heinsen H; Beckmann H Psychiatry Res; 1989 Sep; 29(3):391-3. PubMed ID: 2608799 [No Abstract] [Full Text] [Related]
18. Differential impairments of selective attention due to frequency and duration of cannabis use. Solowij N; Michie PT; Fox AM Biol Psychiatry; 1995 May; 37(10):731-9. PubMed ID: 7640328 [TBL] [Abstract][Full Text] [Related]
19. A nose-brain pathway for psychotropic peptides: evidence from a brain evoked potential study with cholecystokinin. Pietrowsky R; Thiemann A; Kern W; Fehm HL; Born J Psychoneuroendocrinology; 1996 Aug; 21(6):559-72. PubMed ID: 8983091 [TBL] [Abstract][Full Text] [Related]
20. Event-related potentials in alcoholic men: P3 amplitude reflects family history but not alcohol consumption. Pfefferbaum A; Ford JM; White PM; Mathalon D Alcohol Clin Exp Res; 1991 Oct; 15(5):839-50. PubMed ID: 1755518 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]